參考文獻(xiàn)/References:
[1] ZHAO D W,YU M,HU K,et al.Prevalence of nontraumatic osteonecrosis of the femoral head and its associated risk factors in the Chinese population:results from a nationally representative survey[J].Chin Med J(Engl),2015,128(21):2843-2850.
[2] 丁佐佑,陳增淦.股骨頭壞死保頭手術(shù)治療的研究進展[J].中國臨床醫(yī)學(xué),2018,25(5):830-834.
[3] 惠銀銀,劉又斌,王晶,等.非創(chuàng)傷性股骨頭壞死病因的研究進展[J].中醫(yī)正骨,2018,30(2):33-36.
[4] MONT M A,CHERIAN J J,SIERRA R J,et al.Nontraumatic osteonecrosis of the femoral head:where do we stand today?A ten-year update[J].J Bone Joint Surg Am,2015,97(19):1604-1627.
[5] VAN DER JAGT D,MOKETE L,PIETRZAK J,et al.Osteonecrosis of the femoral head:evaluation and treatment[J].J Am Acad Orthop Surg,2015,23(2):69-70.
[6] 陳雷雷,何偉.股骨頭壞死藥物治療進展[J].中華關(guān)節(jié)外科雜志(電子版),2013,7(3):387-389.
[7] 劉道兵,陳衛(wèi)衡.藥物防治激素性股骨頭壞死的研究進展[J].中國矯形外科雜志,2005,13(3):218-219.
[8] 張超,姚晨,沈計榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(3):20-23.
[9] TAKASHIMA K,SAKAI T,HAMADA H,et al.Which classification system is most useful for classifying osteonecrosis of the femoral head?[J].Clin Orthop Relat Res,2018,476(6):1240-1249.
[10] LüRING C,BENIGNUS C,BECKMANN J.Joint-preserving operative treatment of avascular necrosis of the femoral head[J].Orthopade,2018,47(9):745-750.
[11] 周勇,徐祖健,柴天朋,等.非創(chuàng)傷性股骨頭壞死骨髓水腫與磁共振分期的關(guān)系及骨髓水腫發(fā)生機制的初步研究[J].中醫(yī)正骨,2016,28(8):8-12.
[12] ZHANG Q Y,LI Z R,GAO F Q,et al.Pericollapse stage of osteonecrosis of the femoral head:a last chance for joint preservation[J].Chin Med J(Engl),2018,131(21):2589-2598.
[13] 劉予豪,周馳,陳雷雷,等.基于股骨頭壞死圍塌陷期理論的保髖術(shù)式總結(jié)[J].中國修復(fù)重建外科雜志,2017,31(8):1010-1015.
[14] 郭浩山,安龍,劉曉之,等.關(guān)節(jié)鏡輔助下髓芯減壓植骨聯(lián)合介入治療FicatⅡ期股骨頭壞死[J].中國骨與關(guān)節(jié)損傷雜志,2017,32(4):390-392.
[15] SULTAN A A,MONT M A.Core decompression and bone grafting for osteonecrosis of the talus:a critical analysis of the current evidence[J].Foot Ankle Clin,2019,24(1):107-112.
[16] 馮賓,錢文偉,翁習(xí)生,等.髓芯減壓+同種異體骨打壓植骨治療早期股骨頭壞死的療效觀察[J].中國醫(yī)學(xué)科學(xué)院學(xué)報,2015,37(2):133-139.
[17] 馮學(xué)濤,孫魯偉,王景彥,等.燈泡狀病灶清除打壓植骨術(shù)治療股骨頭壞死的療效[J].實用骨科雜志,2016,22(10):878-880.
[18] 楊新明,石蔚,杜雅坤,等.應(yīng)用關(guān)節(jié)鏡技術(shù)微創(chuàng)治療股骨頭早期壞死[J].生物骨科材料與臨床研究,2018,15(3):45-49.
[19] 馬金輝,孫偉,郭萬首,等.股骨頭壞死鉭棒植入后中期隨訪失敗原因分析[J].中華關(guān)節(jié)外科雜志(電子版),2017,11(4):331-337.
[20] ZHANG X,WANG J,XIAO J,et al.Early failures of porous tantalum osteonecrosis implants:a case series with retrieval analysis[J].Int Orthop,2016,40(9):1827-1834.
[21] 鄧云平,李偉.股骨頭壞死早期治療方法研究進展[J].西部醫(yī)學(xué),2017,29(2):292-296.
[22] CHOTANAPHUTI T,THONGPRASERT S,LAORUENGTHANA A.Low molecular weight heparin prevents the progression of precollapse osteonecrosis of the hip[J].J Med Assoc Thai,2013,96(10):1326-1330.
[23] 王得勝,侯毅,劉騰,等.超選擇血管介入聯(lián)合髓芯減壓植骨術(shù)治療早中期股骨頭缺血性壞死的效果觀察[J].中華實用診斷與治療雜志,2019,33(1):35-36.
[24] 張功林,葛寶豐.應(yīng)用阿侖膦酸鈉治療股骨頭缺血性壞死進展[J].實用骨科雜志,2011,17(8):716-718.
[25] CHIU W Y,YANG W S,CHIEN J Y,et al.The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects[J].PLoS One,2018,13(4):e0196419.
[26] YANG Z,LIU H,LI D,et al.The efficacy of statins in preventing glucocorticoid-related osteonecrosis in animal models:a meta-analysis[J].Bone Joint Res,2016,5(9):393-402.
[27] YU X,ZHANG D,CHEN X,et al.Effectiveness of various hip preservation treatments for non-traumatic osteonecrosis of the femoral head:a network meta-analysis of randomized controlled trials[J].J Orthop Sci,2018,23(2):356-364.
相似文獻(xiàn)/References:
[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對兔股骨頭壞死模型
血管內(nèi)皮生長因子表達(dá)的動態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):1.
[3]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長因子和骨形態(tài)發(fā)生蛋白2
在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達(dá)[J].中醫(yī)正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):7.
[4]鮑榮華,王國平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成
最大頻繁關(guān)聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):21.
[7]李文龍,梅沉成,杜貴強,等.微創(chuàng)減壓植骨多孔鉭棒植入治療
ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預(yù)非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):14.
[9]鮑榮華,王國平,夏曉斌,等.直接前入路微創(chuàng)全髖關(guān)節(jié)置換術(shù)治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):20.
[11]陳衛(wèi)衡.中國股骨頭壞死數(shù)據(jù)庫的現(xiàn)狀與挑戰(zhàn)[J].中醫(yī)正骨,2020,32(01):1.
[12]雷志強,曾平,陳衛(wèi)衡,等.中國股骨頭壞死數(shù)據(jù)庫股骨頭壞死流行病學(xué)特點分析[J].中醫(yī)正骨,2020,32(01):4.
[13]周占國,郭浩山,關(guān)濤,等.股骨頭壞死病因的相關(guān)因素分析[J].中醫(yī)正骨,2020,32(01):7.
[14]陳瑞,董博,袁普衛(wèi),等.股骨頭壞死誤診原因分析[J].中醫(yī)正骨,2020,32(01):11.
[15]楊琪,杜炯,孫繼高,等.股骨頭壞死中醫(yī)證型分析[J].中醫(yī)正骨,2020,32(01):14.
[16]曹玉舉,崔朋濤,孫繼高,等.不同ARCO分期和中日友好醫(yī)院分型股骨頭壞死的中醫(yī)證型分布特征研究[J].中醫(yī)正骨,2020,32(01):18.
[17]莊至坤,郭金花,趙巖,等.股骨頭壞死髖關(guān)節(jié)疼痛和活動度與ARCO分期的相關(guān)性分析[J].中醫(yī)正骨,2020,32(01):21.
[18]范亞楠,李文龍,張穎,等.不同病因股骨頭壞死的ARCO分期和中日友好醫(yī)院分型特征研究[J].中醫(yī)正骨,2020,32(01):25.
[19]高歡歡,王向鵬,任浩,等.股骨頭壞死的舌象特征研究[J].中醫(yī)正骨,2020,32(01):28.
[20]薛志鵬,李記天,高歡歡,等.股骨頭壞死舌象特點的聚類分析[J].中醫(yī)正骨,2020,32(01):32.